Responses
Oncolytic and local immunotherapy
Original research
Generation of novel oncolytic vaccinia virus with improved intravenous efficacy through protection against complement-mediated lysis and evasion of neutralization by vaccinia virus-specific antibodies
Compose a Response to This Article
Other responses
No responses have been published for this article.